medline.ch Gastroenterologie Magen-Darm Entzündliche Darmerkrankungen

	Clinical Practice Guideline for the Surgical Management of Ulcerative Colitis. Dis Colon Rectum Lightner AL, Leeds I, McGee MF, Dawes AJ, Peterson CY, Krane MK, Hedrick TL, Gaertner WB. PMID: 42165399 [PubMed - as supplied by publisher]
	Apical Periodontitis May Exacerbate Ulcerative Colitis via Neutrophil Extracellular Trap-Mediated Systemic Inflammation and Intestinal Barrier Disruption in Mice. Int Endod J Zeng Y, Zhang Y, Xiong Y, Zheng P, Wang H, Zhang S, Lin S, Luo Y, Lei H, Chen S, Cai Z, Gan G, Huang X. PMID: 42165292 [PubMed - as supplied by publisher]
	Mesalamine in Treatment of Intestinal Inflammatory Diseases-Formulation-Driven Strategies for Targeted Colonic Therapy and Remission Maintenance. Drug Dev Res Sahoo B, Patel J. PMID: 42163435 [PubMed - indexed for MEDLINE]
	Long-term changes in disease extent and severity in ulcerative colitis: a population-based cohort from the Norwegian HUNT study, (2002-2024). Scand J Gastroenterol Hjelle H, Myklebust TÅ, Granlund AVB, Østvik AE, Ness-Jensen E. PMID: 42161890 [PubMed - as supplied by publisher]
	Intestinal ultrasound to detect postoperative recurrence in patients with Crohn's disease: an international, multidisciplinary, RAND/UCLA appropriateness method study. Lancet Gastroenterol Hepatol Ma C, Albashir S, Allocca M, de Buck van Overstraeten A, Kotze PG, Lu C, Maaser C, Maconi G, Panaccione R, Regueiro M, Rimola J, Spinelli A, Taylor SA, Wilkens R, Bemelman W, Cleveland NK, Gecse KB, Archer S, Kiarasi S, Cornfield LJ, Novak KL. PMID: 42161324 [PubMed - as supplied by publisher]
	MiR-26b-5p Predicts the Severity of Crohn's Disease and the Degree of Malnutrition. Folia Biol (Praha) Sun YH, Wang XX, Wu C. PMID: 42160731 [PubMed - indexed for MEDLINE]
	A novel super-resolution contrast-enhanced ultrasound approach for evaluating inflammatory activity in Crohn's disease. Insights Imaging Wang Y, Ge W, Yu Y, Wei L, Ding W, Cheng R, Huang Y, Dong Y, Du P. PMID: 42159961 [PubMed]
	Native T(1) mapping of the terminal ileum in Crohn's disease: an exploratory study. Acta Radiol Grassi G, Chabert GL, Balestrieri A, Porcu M, Argiolas GM, Cherchi MV, Saba L. PMID: 42159273 [PubMed - as supplied by publisher]
	Inflammatory bowel disease phenotypes in diverse populations: a global comparative analysis. J Crohns Colitis Bernstein CN, Kaplan GG, Nugent Z, Ahuja V, Ananthakrishnan AN, Banerjee R, Burisch J, Chen Y, Epstein D, Forbes AJ, Gonczi L, Gu Y, Gunawan J, Hang DV, Kaibullayeva J, Kopylov U, Kotze PG, Iade B, Lakatos PL, Limsrivilai J, Liang J, Mak JWY, Ng S, Severs M, Shen J, Sood A, Yamamoto-Furusho JK, Yuan S, Wewer MD, Wu K, Windsor JW, Gearry RB, Globalization Cluster of the International Organization for the Study of IBD. PMID: 42159039 [PubMed - indexed for MEDLINE]
	Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus. J Crohns Colitis Wils P, Jairath V, Sands BE, Dignass A, Magro F, Rubin DT, Dotan I, Reinisch W, Dulai P, Gearry R, Ma C, Long M, Armuzzi A, Kobayashi T, Turner D, Vieujean S, Verstockt B, Hart A, Danese S, Peyrin-Biroulet L. PMID: 42159038 [PubMed - indexed for MEDLINE]
	Exosomes in Inflammatory Bowel Disease: Mechanisms, Diagnostic Potential, and Engineering Strategies for Precision Therapy. Int J Med Sci Zhao ZK, Ma JL, Lu F, Wang SJ. PMID: 42158829 [PubMed - indexed for MEDLINE]
	NPHR, FPR, and PLT as predictors of ulcerative colitis severity: a single-center retrospective study in China. Front Med (Lausanne) Yang S, Liang D, Qin Y, Dai F, Zhou G, Zhu F. PMID: 42158139 [PubMed]
	The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study. Pharmacoepidemiol Drug Saf Harrison M, Blitz S, Law M, Tadrous M, Gomes T, Clement F, Rosenfeld G, Anis A, Bansback N. PMID: 42157439 [PubMed - indexed for MEDLINE]
	Vedolizumab for stricturing Crohn's disease of the terminal ileum - an international multicenter cohort study. BMC Gastroenterol El Ouali S, Baker ME, Lu C, Medellin A, Bruining DH, Fletcher JG, Inoue A, Regueiro M, Ottichilo RK, Schoenoff S, Rosentreter R, Bena J, Qazi T, Holubar SD, Gauriloff S, Gandhi NS, Falloon K, Sleiman J, Cohen BL, Goren I, Balci N, Rieder F, Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. PMID: 42157112 [PubMed - as supplied by publisher]
	Comments on "Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study". Intest Res Borrás-Blasco J, Valcuende-Rosique A, Cornejo-Uixeda S. PMID: 42156082 [PubMed - as supplied by publisher]
	Comments on "Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficultto- treat inflammatory bowel disease: a single-center retrospective study in Japan". Intest Res Xu C, Li H. PMID: 42156081 [PubMed - as supplied by publisher]
	Use Patterns of Novel Janus Kinase Inhibitors After the First Safety Alerts: A Nationwide Register-Based Time Series Analysis. Pharmacoepidemiol Drug Saf Rutanen J, Heino P, Sarnola K, Kurko T. PMID: 42156017 [PubMed - indexed for MEDLINE]
	Acute severe ulcerative colitis: efficacy and safety of JAK inhibitors. Expert Opin Pharmacother Bruno A, Bencardino S, D'Amico F, Peyrin-Biroulet L, Danese S. PMID: 42155464 [PubMed - as supplied by publisher]
	Clinicopathological features and cancer-specific survival in young patients with ulcerative colitis-associated colorectal neoplasia: a nationwide cohort study in Japan. Inflamm Bowel Dis Shinagawa T, Komatsu K, Uchino M, Ikeuchi H, Shigeta K, Oka S, Higashi D, Ogawa S, Watanabe K, Shibutani M, Okita Y, Wakai T, Mizuuchi Y, Okamoto K, Yamada K, Sato Y, Ogino T, Kimura H, Takahashi K, Hida K, Kinugasa Y, Ishida F, Okuda J, Daito K, Yamamoto T, Yamamoto S, Koyama F, Hiro J, Komori K, Shida D, Arakaki J, Fujita F, Matsuyama T, Ueno H, Ochiai H, Maemoto A, Nezu R, Sasaki S, Sunami E, Noguchi T, Sugihara K, Ajioka Y, Ishihara S, Study Group for Inflammatory Bowel Disease Associated Intestinal Cancers by Japanese Society for Cancer of the Colon and Rectum. PMID: 42154979 [PubMed - as supplied by publisher]
	Patient acceptability of partial enteral nutrition as a concomitant therapy to Adalimumab in adults with active Crohn's disease - BIOPIC trial. Ann Nutr Metab Fandinga C, Clowe J, White B, Campbell I, Seenan JP, Brownson E, Milling S, Koutsos A, Ho GT, Mowat C, Robertson E, Gaya DR, Kefayat A, Din S, MacDonald J, Gerasimidis K. PMID: 42154650 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 57666

Seite 1 von 2884



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung